Back
ESC Premium Access

Association of adherence and treatment intensity of lipid-lowering therapy with cardiovascular outcomes and all-cause mortality in very high-risk patients in Germany

Session: Poster Session 1 - Lipids
Topic: Drug therapy
Speaker: Professor I. Ahrens (Cologne, DE)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Professor Ingo Ahrens

Hospital der Augustinerinnen, Cologne (Germany)
29 presentations
10 followers

14 more presentations in this session

Patient characteristics and treatment patterns in patients on lipid-lowering therapies following an acute coronary syndrome in France

Speaker: Professor E. Bruckert (Paris, FR)

Access
Abstract
Slides
Like
Thumbnail

What is the most important residual risk after achievement of appropriate low-density lipoprotein cholesterol lowering therapy in secondary prevention of Japanese patients?

Speaker: Doctor A. Endo (Izumo, JP)

Access
Abstract
Like
Thumbnail

Relative fat mass (RFM) is a better predictor of dyslipidemia and metabolic syndrome than body mass index (BMI).

Speaker: Doctor O. Kobo (Hadera, IL)

Access
Abstract
Slides
Like
Thumbnail

Low levels of low density lipoprotein cholesterol and cardiovascular, cancer and all-cause mortality outcomes

Speaker: Professor K. Sung (Seoul, KR)

Access
Abstract
Like
Thumbnail

Effects of personalized therapy-effect predictions on statin treatment decisions by patients and physicians: a three-armed, blinded, randomized controlled trial

Speaker: Ms N. Jaspers (Utrecht, NL)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 1 - Lipids

Speakers: Professor I. Ahrens, Professor E. Bruckert, Doctor A. Endo, Doctor O. Kobo, Professor K. Sung...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

novartis Explore sponsored resources